窪蹋勛圖厙

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 窪蹋勛圖厙 News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Mar 11 2026

Full Issue

FDA OKs Leucovorin For Neurological Disorder, But Not As Autism Treatment

The Trump administration has touted the synthetic vitamin B9 as a way to treat autism, but there is insufficient data to support the drug's use for it, an FDA official said. The new approval is for the treatment of cerebral folate deficiency.

The Food and Drug Administration on Tuesday announced a new approved use for the drug leucovorin, a synthetic form of vitamin B9 that the Trump administration has touted as a treatment for autism symptoms. But the new approval is not for autism its for cerebral folate deficiency, a rare neurological condition characterized by low levels of vitamin B9 in the brain. (Bendix, 3/10)

On autism and Medicaid

When Meghann Mitchell first launched her autism-therapy business in 2019, she took aim at an unlikely source of profit: Indianas taxpayer-funded Medicaid program, the public insurance system for the poor. The bet paid off. In 2023, the state paid Mitchells company, Piece by Piece Autism Centers, $29 million to provide therapy to just 84 patientsabout $340,000 a childaccording to a Wall Street Journal analysis of Medicaid billing records. (Weaver, McGinty and Wilde Mathews, 3/10)

More on the Trump administration

HHS Secretary Robert F. Kennedy Jr. was having rotator cuff surgery Tuesday, a spokesperson told MedPage Today. Kennedy plans to return to the office March 16, the spokesperson said. That person did not provide details about the reason for the procedure or which shoulder was repaired, and did not provide an update on his condition. Since his tenure at HHS began, Kennedy has frequently engaged in various physical activities publicly to promote his "Make America Healthy Again" agenda, including doing pull-ups at an airport event. (McCreary, 3/10)

The Social Security Administrations internal watchdog is investigating a complaint that alleges a former U.S. DOGE Service employee claimed he had access to two highly sensitive agency databases and planned to share the information with his private employer a claim that, if true, would constitute an unprecedented breach of security protocols at an agency that serves more than 70 million Americans. (Kornfield, Dwoskin and Rein, 3/10)

Dr. Lara Jones still remembers her visceral reaction to the image of Liam Ramos. It wasnt the most famous one, of the 5-year-old boy in a blue bunny winter hat and superhero backpack with ICE officers behind him. It was one from days later, of Liam slumped in his fathers arms while both were in custody in Texas. (Rodriguez, 3/10)

窪蹋勛圖厙 News: Listen To The Latest '窪蹋勛圖厙 News Minute'

Zach Dyer reads the weeks news: The Trump administration is calling for sharp restrictions on direct-to-consumer drug ads, and for some people facing skyrocketing health insurance costs, becoming eligible for Medicare because of a new diagnosis is a terrible irony. (Cook, 3/10)

In related news on transgender health care

Though the SAVE America Act (formerly the SAVE Act) cleared the House in February, the Senate has avoided taking it up for a vote. Now, President Donald Trump has raised a series of demands that wont make its passage any easier. Trump announced in a weekend social media post that he would not sign other bills until this is passed, and not the watered down version go for the gold, a revision that could now put anti-trans measures in the bill. (Martinez and Rummler, 3/10)

Gabrielle Jones-Radtke has lived in El Paso for nearly her entire life. She loves El Paso its community, its culture, its recent growth but her favorite factor is its predictability. If youre young, you know, maybe thats not the best thing, Jones-Radtke said. But once you get older and have a family, predictability is everything. But a series of unpredictable circumstances is forcing her to move her family about 25 miles away to New Mexico. (Johnstone, 3/10)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, June 5
  • Thursday, June 4
  • Wednesday, June 3
  • Tuesday, June 2
  • Monday, June 1
  • Friday, May 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 窪蹋勛圖厙
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

穢 2026 KFF